v3.22.1
BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - GSD and Eskar Acquisitions (Details)
 12 Months Ended
Sep. 15, 2021
USD ($)
ft²
Dec. 31, 2021
USD ($)
Jul. 01, 2021
USD ($)
Mar. 23, 2021
USD ($)
Feb. 26, 2021
USD ($)
Feb. 26, 2021
ft²
Feb. 26, 2021
a
Acquisition-date fair value of total consideration transferred [abstract]              
Exchangeable Stock Exchange Ratio   1          
Promissory notes payable DocHouse Agreement              
Acquisition-date fair value of total consideration transferred [abstract]              
Promissory note       $ 22,500,000      
Eskar Asset Acquisition              
Acquisition-date fair value of total consideration transferred [abstract]              
Cash $ 1,000,000            
ASSETS ACQUIRED              
Intangible assets - host community agreements     $ 1,000,000        
Total assets acquired at fair value     1,000,000        
LIABILITIES ASSUMED              
Consideration transferred     $ 1,000,000        
Q3 2021              
ASSETS ACQUIRED              
Cash 579,560            
Inventory, net 3,237,125            
Prepaid expenses and other assets 67,449            
Intangible assets - licenses/permits 172,000,000            
Intangible assets - host community agreements 1,000,000            
Right-of-use assets - operating 13,234,034            
Property, plant and equipment 30,699,183            
Deposits and other assets 193,610            
Total assets acquired at fair value 221,010,961            
LIABILITIES ASSUMED              
Trade payables 1,658,180            
Accrued liabilities 444,784            
Advance from related parties 22,750,176            
Lease liabilities - operating 13,025,508            
Debts payable 3,000,000            
Total liabilities assumed at fair value 40,878,648            
Goodwill 11,523,843            
Consideration transferred 191,656,156            
GSD Business Combination              
Acquisition-date fair value of total consideration transferred [abstract]              
Cash 41,860,310            
Debt Payable 29,490,630            
Shares Issued $ 29,744,216            
Shares Issued, shares 1,511,334            
Contingent Consideration $ 89,561,000            
Total Consideration 190,656,156            
Promissory note $ 29,500,000            
Area of cultivation and production facilities | ft² 30,000            
Area of cultivation and production facilities under construction | ft² 75,000            
Measurement period adjustments to intangible assets increase in amount   $ 12,000,000.0          
ASSETS ACQUIRED              
Cash $ 579,560            
Inventory, net 3,237,125            
Prepaid expenses and other assets 67,449            
Intangible assets - licenses/permits 172,000,000            
Right-of-use assets - operating 13,234,034            
Property, plant and equipment 30,699,183            
Deposits and other assets 193,610            
Total assets acquired at fair value 220,010,961            
LIABILITIES ASSUMED              
Trade payables 1,658,180            
Accrued liabilities 444,784            
Advance from related parties 22,750,176            
Lease liabilities - operating 13,025,508            
Debts payable 3,000,000            
Total liabilities assumed at fair value 40,878,648            
Goodwill 11,523,843            
Consideration transferred $ 190,656,156            
GSD Business Combination | Exchangeable Shares              
Acquisition-date fair value of total consideration transferred [abstract]              
Percentage of discount rate attributed to the contractual restrictions 9.20%            
GSD Business Combination | Exchangeable Shares | Bottom of range              
Acquisition-date fair value of total consideration transferred [abstract]              
Lock-up provision 4 months            
GSD Business Combination | Exchangeable Shares | Top of range              
Acquisition-date fair value of total consideration transferred [abstract]              
Lock-up provision 12 months            
Liberty Health Sciences              
Acquisition-date fair value of total consideration transferred [abstract]              
Shares Issued         $ 399,499,188    
Shares Issued, shares         12,670,958    
Total Consideration         $ 406,344,000    
Area of cultivation and production facilities           300,000 387
Measurement period adjustments to inventory decrease in amount   6,600,000          
Measurement period adjustments to property, plant and equipment decrease in amount   1,700,000          
Measurement period adjustments to right of use assets decrease in amount   2,100,000          
Measurement period adjustments to income taxes decrease in amount   1,500,000          
Measurement period adjustments to deferred taxes increase in amount   1,400,000          
Measurement period adjustments to lease liabilities decrease in amount   $ 2,100,000          
ASSETS ACQUIRED              
Cash         6,650,137    
Inventory, net         46,842,186    
Prepaid expenses and other assets         817,824    
Intangible assets - licenses/permits         270,000,000    
Right-of-use assets - operating         11,750,150    
Right-of-use assets - finance, net         378,992    
Property, plant and equipment         56,745,883    
Deposits and other assets         619,377    
Total assets acquired at fair value         393,804,549    
LIABILITIES ASSUMED              
Trade payables         3,274,256    
Accrued liabilities         5,383,075    
Deferred tax liabilities         71,962,667    
Lease liabilities - operating         11,693,248    
Lease liabilities - finance         378,992    
Income tax payable         1,818,520    
Accrued interest         153,057    
Debts payable         7,479,389    
Total liabilities assumed at fair value         102,143,204    
Goodwill         114,682,655    
Consideration transferred         406,344,000    
Liberty Health Sciences | Subordinate Voting Shares              
Acquisition-date fair value of total consideration transferred [abstract]              
Shares Issued         $ 2,400,000    
Shares Issued, shares         75,864    
Liberty Health Sciences | Exchangeable Shares              
Acquisition-date fair value of total consideration transferred [abstract]              
Shares Issued         $ 4,500,000    
Shares Issued, shares         248,412